Guardian Pharmacy Services (GRDN) Accounts Payables (2023 - 2026)

Guardian Pharmacy Services has disclosed Accounts Payables across 4 years of filings, most recently posting $108.6 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $108.6 million, up 6.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $108.6 million (up 6.77% YoY), and the FY2025 annual result was $116.2 million, up 13.46% from the prior year.
• Accounts Payables came in at $108.6 million for Q1 2026 at Guardian Pharmacy Services, down from $116.2 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $121.7 million in Q3 2025 to a low of $85.6 million in Q4 2023.
• The 4-year median for Accounts Payables is $105.9 million (2024), against an average of $106.0 million.
• Across the five-year window, Accounts Payables climbed 19.65% in 2024 and increased 6.77% in 2026, its largest moves.
• Guardian Pharmacy Services' Accounts Payables stood at $85.6 million in 2023, then climbed by 19.65% to $102.4 million in 2024, then advanced by 13.46% to $116.2 million in 2025, then declined by 6.59% to $108.6 million in 2026.
• The last three Accounts Payables figures came in at $108.6 million (Q1 2026), $116.2 million (Q4 2025), and $121.7 million (Q3 2025), per Business Quant data.